3 months Assenagon Asset Management S.A. Takes Position in Spyre Therapeutics, Inc. (NASDAQ:SYRE) MarketBeat
Assenagon Asset Management S.A. purchased a new position in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 1,142,768 shares of the compan…
X